BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND MUC16, CA125, CA-125 AND Treatment
14 results:

  • 1. Engineered exosome as a biological nanoplatform for drug delivery of Rosmarinic acid to improve implantation in mice with induced endometritis.
    Taravat M; Asadpour R; Jafari Jozani R; Fattahi A; Khordadmehr M; Hajipour H
    Syst Biol Reprod Med; 2024 Dec; 70(1):3-19. PubMed ID: 38323586
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Genetic Factors and Long-term treatment-Related Neurocognitive Deficits, Anxiety, and Depression in Childhood leukemia Survivors: An Exome-Wide Association Study.
    Petrykey K; Lippé S; Sultan S; Robaey P; Drouin S; Affret-Bertout L; Beaulieu P; St-Onge P; Baedke JL; Yasui Y; Hudson MM; Laverdière C; Sinnett D; Krajinovic M
    Cancer Epidemiol Biomarkers Prev; 2024 Feb; 33(2):234-243. PubMed ID: 38051303
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Borderline ovarian tumors: French guidelines from the CNGOF. Part 1. Epidemiology, biopathology, imaging and biomarkers.
    Huchon C; Bourdel N; Abdel Wahab C; Azaïs H; Bendifallah S; Bolze PA; Brun JL; Canlorbe G; Chauvet P; Chereau E; Courbiere B; De La Motte Rouge T; Devouassoux-Shisheboran M; Eymerit-Morin C; Fauvet R; Gauroy E; Gauthier T; Grynberg M; Koskas M; Larouzee E; Lecointre L; Levêque J; Margueritte F; Mathieu D'argent E; Nyangoh-Timoh K; Ouldamer L; Raad J; Raimond E; Ramanah R; Rolland L; Rousset P; Rousset-Jablonski C; Thomassin-Naggara I; Uzan C; Zilliox M; Daraï E
    J Gynecol Obstet Hum Reprod; 2021 Jan; 50(1):101965. PubMed ID: 33160106
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Regulation of cell activation by A20 through STAT signaling in acute lymphoblastic leukemia.
    Canh NX; Giang NV; Nghia VX; Sopjani M; Ngan NTT; Hoang NH; Xuan NT
    J Recept Signal Transduct Res; 2021 Aug; 41(4):331-338. PubMed ID: 32808859
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Expression of RRBP1 in epithelial ovarian cancer and its clinical significance.
    Ma J; Ren S; Ding J; Liu S; Zhu J; Ma R; Meng F
    Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31285390
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Controversies in the management of ovarian tumours in prepubertal children - A BAPS and UK CCLG Surgeons Cancer Group National Survey.
    Braungart S; Craigie RJ; Losty PD
    J Pediatr Surg; 2018 Nov; 53(11):2231-2234. PubMed ID: 29395152
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. CEA, AFP, ca125, CA153 and CA199 in malignant pleural effusions predict the cause.
    Wang XF; Wu YH; Wang MS; Wang YS
    Asian Pac J Cancer Prev; 2014; 15(1):363-8. PubMed ID: 24528057
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Serum carbohydrate antigen 125 is not an independent prognostic factor in patients with chronic lymphocytic leukemia.
    Zou ZJ; Fan L; Wang L; Zhang R; Zhang LN; Yang S; Li JY; Xu W
    Cancer Biomark; 2012; 12(4):169-76. PubMed ID: 23568007
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Phase II clinical study of the combination chemotherapy regimen of irinotecan plus oral etoposide for the treatment of recurrent ovarian cancer (Tohoku Gynecologic Cancer Unit 101 Group Study).
    Shoji T; Takatori E; Omi H; Kumagai S; Yoshizaki A; Yokoyama Y; Mizunuma H; Fujimoto T; Takano T; Yaegashi N; Tase T; Nakahara K; Kurachi H; Nishiyama H; Sugiyama T
    Int J Gynecol Cancer; 2011 Jan; 21(1):44-50. PubMed ID: 21330830
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Increased serum tumor markers (ca125 and CA15.3) in primary plasma cell leukemia: a case report and review of the literature.
    de Larrea CF; Cibeira MT; Vallansot R; Colomo L; Bladé J
    Clin Lymphoma Myeloma; 2008 Oct; 8(5):312-4. PubMed ID: 18854288
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Hairy cell leukaemia presenting with ascites, pleural effusion and increased CA 125 serum level.
    Dinçol G; Doğan O; Küçükkaya RD; Gül E; Kahraman R; Ağan M
    Neth J Med; 2008 Jan; 66(1):23-6. PubMed ID: 18219064
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. A phase 2 study of the cytotoxic immunoconjugate CMB-401 (hCTM01-calicheamicin) in patients with platinum-sensitive recurrent epithelial ovarian carcinoma.
    Chan SY; Gordon AN; Coleman RE; Hall JB; Berger MS; Sherman ML; Eten CB; Finkler NJ
    Cancer Immunol Immunother; 2003 Apr; 52(4):243-8. PubMed ID: 12669249
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Allogeneic hematopoietic stem cell transplantation in ovarian carcinoma: results of five patients.
    Bay JO; Fleury J; Choufi B; Tournilhac O; Vincent C; Bailly C; Dauplat J; Viens P; Faucher C; Blaise D
    Bone Marrow Transplant; 2002 Jul; 30(2):95-102. PubMed ID: 12132048
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. [The value of etoposide (VP-16) in the therapy of refractory ovarian cancer].
    Marth C; Pointner E; Zeimet AG; Abfalter E; Koza A; Windbichler G; Hetzel H; Dapunt O
    Geburtshilfe Frauenheilkd; 1993 May; 53(5):303-7. PubMed ID: 8514100
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.